Introduction {#S1}
============

Lyme disease, multisystem and multistage infectious disease, is the most common tick-borne disease in Europe and North America and is caused by infection with spirochetes of the *Borrelia burgdorferi* sensu lato genospecies complex. The different genospecies are associated with distinct clinical manifestations. Lyme neuroborreliosis (LNB) is more common in Europe than in the United States and typically presents as Bannwarth's syndrome including lymphocytic meningitis, cranial neuritis, and radiculoneuritis. These manifestations can occur separately or together ([@B1], [@B2]).

In most cases, cerebrovascular events are attributed to arteriosclerosis or cerebral embolism, but sometimes infectious causes are found. *B. burgdorferi*-induced CNS vasculitis is believed to be a very rare manifestation of LNB and may manifests as ischemic stroke ([@B3]), transient ischemic attack (TIA) ([@B4]), and very rarely as intracranial hemorrhage (ICH) ([@B5], [@B6]), cerebral venous sinus thrombosis (CVST) ([@B7], [@B8]), or aneurysm ([@B9], [@B10]).

To date, there has been no comprehensive systematic review of the literature on cerebrovascular manifestations of LNB with the aim of clarifying the epidemiology, clinical course, imaging studies, and the outcome of these rare manifestations of LNB. We aimed to collect all the articles with patients who presented with vasculitis and stroke due to LNB and systematically review the data reported.

Materials and Methods {#S2}
=====================

We conducted a systematic review of the medical literature to identify all published cases of cerebrovascular manifestations of LNB using the online databases of MEDLINE/PubMed, Web of Science and Google Scholar (between May 1987 and December 2016). There were no language restrictions; non-English language articles were included and translated. The search terms were "Lyme disease" OR "neuroborreliosis" OR "borreliosis" OR "*Borrelia burgdorferi*" AND one of the following terms: "vasculitis" OR "vasculopathy" OR "angiopathy" OR "stroke" OR "transient ischemic attack" OR "intracranial haemorrhage" OR "subarachnoid hemorrhage" OR "venous thrombosis." We reviewed titles, abstracts, and full articles to assess if our inclusion criteria had been met. References in each identified articles were reviewed to identify additional cases that we had not found by using the search terms. In addition, the author, date, city, and hospital of each case report were verified for duplication of reporting. The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.

Our inclusion criteria included (1) clinical and/or radiologic evidence of cerebrovascular manifestations of LNB (vasculitis, stroke, TIA, or aneurysms), (2) mandatory confirmation of LNB according to the European Federation of Neurological Societies (EFNS) guidelines (definite or possible) ([@B11]) or guidelines of the Infectious Diseases Society of America ([@B12]) and the American Academy of Neurology ([@B13]), and (3) excluded other stroke risk factors (e.g., atrial fibrillation or infective endocarditis, neurosyphilis, and other infectious causes).

Information from each article was extracted and entered into Microsoft Excel (2007). We extracted the following data from each article: age, sex, country of origin, history of tick bite, preceding symptoms of Lyme disease, time from onset of symptoms suggestive of Lyme disease to onset of symptoms of stroke (or TIA), neurological symptoms at presentation, the CSF cells, protein and glucose levels, imaging studies performed with evaluation of distribution of lesions, treatment, and outcome. Stroke was defined according to the World Health Organization as "rapidly developing clinical signs of focal (or global) disturbance of cerebral function, with symptoms lasting 24 h or longer or leading to death, with no apparent cause other than of vascular origin." TIA was defined as a transient episode of cerebral dysfunction lasting less than 24 h ([@B14]).

Based on vascular studies, which were available in most cases, we classified LNB-associated vasculitis into three main groups: (1) large-sized blood vessels vasculitis; (2) small-sized blood vessels vasculitis, or (3) variable-sized blood vessels vasculitis (both large- and small-sized vessels). Large vessels included internal carotid arteries (ICA), the vertebral arteries (VA), the anterior cerebral artery (ACA) and their main branches, the middle cerebral arteries (MCA) and their main branches, the posterior cerebral arteries (PCA), the basilar artery (BA) and their main branches, the transverse sinuses, the sigmoid sinuses, and the superior sagittal sinus. Small vessels included the small penetrating arteries (e.g., the lenticulostriate arteries) that supplied the deep structures of the brain.

On account of the fact that this was a review of published literature, the ethics committee approval was not required. Statistical analysis was performed using the STATISTICA 10 software.

Results {#S3}
=======

After a strict selection process, a total of 63 manuscripts fulfilled the inclusion criteria and were reviewed in this study ([@B3]--[@B10], [@B15]--[@B70]) (Figure [1](#F1){ref-type="fig"}). We excluded four patients from three manuscripts because they did not meet the criteria for LNB ([@B9], [@B37], [@B71]). Finally, we analyzed 88 individual cases from these manuscripts. The median age of the patients at the time of diagnosis was 46 (range from 4 to 77 years), 47 patients (53.4%) were male; 52 (59.1%) of patients were younger than 50 years. There were 15 pediatric cases. Most patients were from countries with high incidence of reported Lyme disease ([@B72]). Reports from the following three countries account for more then the 50% of the included cases: 16 (25.4%) from Germany, 9 (14.3%) from Switzerland, and 8 (12.7%) from France. The clinical and epidemiological characteristics of patients are shown in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}. Data Sheet S1 in the Supplementary Material presents detailed clinical features, CSF cytosis, and imaging studies of all reported cases.

![**Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart illustrating the number of included and excluded studies in the systematic review on cerebrovascular manifestations of Lyme neuroborreliosis**.](fneur-08-00146-g001){#F1}

###### 

**Epidemiological characteristics of patients with cerebrovascular manifestations of Lyme neuroborreliosis**.

                                                          *n*/*N* (%)
  ------------------------------------------------------- ---------------
  **Characteristic**                                      
  Median age, years                                       46 (4--77)
  Male sex                                                47/88 (53.4%)
  **Origin of the manuscripts**                           
  Germany                                                 16/63 (25.4%)
  Switzerland                                             9/63 (14.3%)
  France                                                  8/63 (12.7%)
  United States                                           5/63 (8%)
  Netherlands                                             5/63 (8%)
  Sweden                                                  4/63 (6.3%)
  Croatia                                                 3/63 (4.8%)
  Austria                                                 3/63 (4.8%)
  Norway                                                  2/63 (3.2%)
  Finland                                                 2/63 (3.2%)
  Belgium                                                 2/63 (3.2%)
  Poland                                                  1/63 (1.6%)
  Spain                                                   1/63 (1.6%)
  Turkey                                                  1/63 (1.6%)
  United Kingdom                                          1/63 (1.6%)
  **Response to treatment**                               
  Complete                                                64/85 (75.3%)
  Incomplete/stable with residual neurological deficits   17/85 (20%)
  Fatal                                                   4/85 (4.7%)

*n/N (%)---n is the number of patients in which the variable was present and N the total number of patients for which that particular variable was reported*.

###### 

**Clinical characteristics of patients with cerebrovascular manifestations of Lyme neuroborreliosis (LNB)**.

  Prodromal clinical course                                                                                           *n*/*N* (%)
  ------------------------------------------------------------------------------------------------------------------- --------------------------------
  History of tick bite                                                                                                40/68 (58.8%)
  History of erythema migrans                                                                                         15/57 (26.3%)
  History of headache                                                                                                 41/65 (63.1%)
  History of radiculitis                                                                                              20/58 (34.5%)
  History of cranial neuritis                                                                                         18/59 (31%)
  History of arthritis                                                                                                5/56 (9%)
  **CSF analysis**                                                                                                    
  Median cytosis                                                                                                      77.5 cells/μL (range 1--2.200)
  Median protein level                                                                                                1.400 mg/L (range 162--7.458)
  Median glucose level                                                                                                1.7 mmol/L (range 0.7--4.2)
  **Type of cerebrovascular manifestation of LNB**                                                                    
  Ischemic stroke                                                                                                     67/88 (76.1%)
  Transient ischemic attack                                                                                           10/88 (11.4%)
  Cerebral venous sinus thrombosis (CVST)                                                                             3/88 (3.4%)
  Intracranial hemorrhage                                                                                             3/88 (3.4%)
  SAH                                                                                                                 1/88 (1.1%)
  Ischemic stroke + CVST                                                                                              1/88 (1.1%)
  Ischemic stroke + aneurysm                                                                                          1/88 (1.1%)
  SAH + aneurysm                                                                                                      1/88 (1.1%)
  **Vascular studies (magnetic resonance angiography, computed tomography angiography, DSA, transcranial Doppler)**   **66/88 (75%)**
  **Affected vessels**                                                                                                
  Large-sized                                                                                                         42/66 (63.6%)
  Small-sized                                                                                                         9/66 (13.6%)
  Variable-sized                                                                                                      1/66 (1.5%)
  **Affected areas of circulation**                                                                                   
  Posterior                                                                                                           31/82 (37.8%)
  Anterior                                                                                                            20/82 (24.4%)
  Anterior + posterior                                                                                                31/82 (37.8%)
  **Distribution of lesions on CT and/or MRI**                                                                        
  Single                                                                                                              25/88 (28.4%)
  Multiple                                                                                                            50/88 (56.8%)
  No lesions                                                                                                          13/88 (14.8%)

*n/N (%)---n is the number of patients in which the variable was present and N the total number of patients for which that particular variable was reported*.

About 40 (58.8%) of patients had a history of tick bite, and about 15 (26.3%) of patients had a history of preceding erythema migrans. Forty-one (63.1%) of patients reported a history of headache, 20 (34.5%) of patients had a history of radiculitis, and 18 (31%) had a history of cranial neuritis. About five (9%) of patients had a history of arthritis. The median interval from symptom onset suggesting Lyme disease to first cerebrovascular manifestation of LNB was 3.5 months (range 0--48 months). In about 40.3% of patients, cerebrovascular LNB was the first manifestation. In 54 (61.4%) of patients, the symptoms occurred single and in 33 (37.5%) of cases were recurrent before the diagnosis of cerebrovascular LNB was made and the antibiotic treatment was commenced.

The most common cerebrovascular manifestation of LNB was ischemic stroke---67 cases (76.1%), followed by TIA---10 cases (11.4%). The rarest manifestations were CVST---three cases (3.4%), ICH---three cases (3.4%), SAH---three cases (1.1%), one case of ischemic stroke coexisting with CVST (1.1%) and with intracranial aneurysms in another case (1.1%), as well as one case of coexistence of SAH with intracranial aneurysm (1.1%). As far as available, in patients whose imaging examination showed pathological changes, it was alleged that the posterior cerebral circulation was affected alone in 31 patients (37.8%), while the anterior circulation was affected alone in 20 patients (24.4%). The anterior and posterior circulations were simultaneously affected in 31 cases (37.8%). All patients underwent MRI and/or CT of the brain. Among them, 75 patients (85.2%) had parenchymal brain lesions diagnosed at imaging; in the remaining patients, there were no parenchymal brain lesions. These lesions were multiple in 50 patients (66.7%) and single in 25 patients (33.3%). In 9 of 13 patients who did not show any parenchymal lesions on MRI and/or CT, cerebral angiography and/or transcranial Doppler (TCD) were performed simultaneously, visualizing the changes suggestive of vasculitis in all these cases; 4 of these 13 cases had performed neither TCD nor cerebral angiography. Among 27 patients who had simultaneously performed MRI and CT of the brain, parenchymal brain lesions were seen only on MRI in 41% of patients and were not seen on CT. Among patients for whom data on MRI meningeal enhancement were available, it was seen only in 13 patients. According to available data on vascular studies, among 66 patients (75%) who underwent such studies \[conventional angiography, magnetic resonance angiography (MRA), computed tomography angiography (CTA), or TCD\], 52 cases (78.8%) showed vascular abnormalities suggestive of vasculitis. Vascular studies showed large-sized blood vessels vasculitis in 63.6% of patients and variable-sized blood vessels vasculitis in 13.6% of patients followed by exclusively small-sized blood vessels vasculitis only in one case. The most common affected vessels (bilaterally or unilaterally) were MCA---in 19 cases, BA---in 17 cases, ACA---in 16 cases, PCA---in 9 cases, VA---in 8 cases, intracranial part of ICA---in 7 cases, and the penetrating arteries supplying the deep-seated structures---in 5 cases.

All patients underwent lumbar puncture as part of the diagnostic workup, and among the patients in whom CSF results were reported in the manuscripts, 96.2% of them had lymphocytic pleocytosis and 90% had increased protein level. The median CSF cytosis was 77.5 cells/μL (range 1--2.200), and the median CSF protein concentration was 1.400 mg/L (range 162--7.458). Among patients for whom data on CSF glucose level were available, 74% of them had decreased level of glucose \[the median CSF glucose level was 1.7 mmol/L (range 0.7--4.2)\]. Four patients had biopsy-proven CNS vasculitis. In the remaining patients, biopsy and histopathology of the brain were not performed.

The majority of patients were treated with ceftriaxone or penicillin. Data on additional treatment with steroids were available for 55 patients, wherein at least 25 of them (45.5%) received steroids, either *per os* or intravenously. Considering the reports wherein, information about antiplatelet and/or anticoagulation therapy was available, about 86.8% of the patients received such treatment. In three patients clinical improvement was achieved only after additional immunosuppressive therapy with cyclophosphamide.

Data on outcome were available in 85 cases. A complete response to antibiotic treatment with halted progression of the disease and no recurrence of cerebral ischemia or recuperation from neurological deficits was achieved in the vast number of patients (75.3%). The overall mortality rate was 4.7%. Among patients who died, posterior circulation was affected in two cases, and multiple vascular territories were affected in two cases.

Discussion {#S4}
==========

In this systematic review of the literature, we have analyzed a large number of cases of CNS vasculitis and stroke associated with infection with *B. burgdorferi*, published as single case reports or small series. Although no gender predisposition was observed, the present study shows that patient with LNB-associated vasculitis are relatively young (median age 46 vs. 73 years in the one population-based stroke register from Europe) ([@B73]). However, this is probably due to the fact that the diagnostics for the causes of vasculitis and stroke is studied more accurately in younger patients. LNB seems to be a rare cause of vasculitis and stroke. In the study by Hammers-Berggren et al., including 281 patients with a diagnosis of stroke or TIA, 8% of them had positive serology for *B. burgdorferi* infection, but only one of them had stroke-like symptoms due to LNB. It suggests that screening for *B. burgdorferi* infection is not indicated in all patients with stroke ([@B27]). In the study by Back et al., the estimated frequency of cerebral vasculitis in patients with Lyme borreliosis amounted to 0.3% ([@B57]). In another study of 330 patients with LNB from Bavaria and Hesse (Germany) conducted by Oschmann et al., this variant has been seen in 1% of the patients ([@B74]). In typical cases of LNB-associated vasculitis, the patients live in an endemic area and have a medical history of tick bite, erythema migrans, headache, radiculitis, and/or cranial neuritis. The patients may also report non-specific complaints, such as fatigue or difficulty concentrating. Thus, it is important to take a detailed medical history from the patients. The case reports came predominantly from Europe, while only five cases were reported from the United States, which is related to the presence of *Borrelia garinii* in Europe, which is the most neurotropic genospecies of *Borrelia*. It should be noted that one of these five patients was infected with *B. burgdorferi* in Europe and diagnosed in the United States ([@B23]).

Parenchymal brain lesions suggestive of ischemia were present in the majority of patients, and in 66.7% of cases, they were multiple, which is typical for CNS vasculitis. MRI is the most sensitive imaging technique for detection of parenchymal changes associated with LNB vasculitis. In LNB, MRI may show meningeal enhancement after contrast administration; however, it is rarely reported. In this study, it was seen only in a small number of patients. Diagnosis of LNB-associated CNS vasculitis is primarily based on radiological investigations such as MRI and MRA or conventional angiography. As shown by the results, LNB-associated vasculitis affects mainly the large/medium-sized vessels causing single or multiple areas of stenosis and dilatation and as the end result occlusion leading to ischemia and stroke. In some patients presented with stroke, angiographic showed no features of vasculitis. Normal angiography may be due to the delay between the stroke symptoms onset and the radiological examination. Moreover, it is important to bear in mind that LNB-associated vasculitis may also involve small blood vessels, which are below the resolution of conventional angiography. MRA and CTA have even less sensitivity and most of the reported cases had performed such type of angiographic procedures. Therefore, a negative angiogram does not exclude the diagnosis of vasculitis ([@B75]).

CVST, ICH, SAH, and aneurysms were the rarest cerebrovascular complications. There is known association of another spirochete, *Treponema pallidum* causing syphilis, to aneurysm formation, indicates that there might be a causative relationship between Lyme disease, similar to syphilis in different stages of the disease, and aneurysm formation ([@B76], [@B77]). It is worth pointing out that a recent study on a group of 96 patients diagnosed with abdominal aortic aneurysms points out to a link between infection with *B. burgdorferi* and abdominal aortic aneurysms ([@B78]).

According to the literature, infection of CNS with *B. burgdorferi* typically leads to lymphocytic pleocytosis and increased CSF protein concentration ([@B79], [@B80]). In this study, CSF analysis demonstrated low median glucose level, which is atypical for LNB, wherein glucose level is usually normal. The combination of lymphocytic pleocytosis, elevated protein, and hypoglycorrhachia resembles tuberculous meningitis.

When a clinical diagnosis of LNB-associated vasculitis is suspected and supported by lesions on MRI or CT, further diagnostic testing should be performed, including CSF analysis and *B. burgdorferi* antibody testing of serum and CSF ([@B2]). To prove *B. burgdorferi*-associated CNS involvement, demonstration of *B. burgdorferi* intrathecal antibody production is used by calculating the CSF to serum antibody index (AI). The anti-*Borrelia* AI have about 80% sensitivity in LNB of short duration (\<6 weeks) and almost 100% sensitivity within a few months and in late LNB. In the case of negative AI, the diagnosis of LNB may be made if there are positive *B. burgdorferi* antibodies in the serum and symptoms suggestive of CNS involvement. A positive AI may persist for years after successful therapy ([@B11]).

In our review, only a small number of cases had brain biopsy. It should be emphasized that only brain biopsy can provide a definite diagnosis of CNS vasculitis, but because it is an invasive diagnostic procedure, it is barely performed.

As can be seen from the results, LNB-induced vasculitis is highly responsive to appropriate antimicrobial treatment similarly to other forms of Lyme disease, but it is obvious that in some cases, especially in those where antibiotic therapy was delayed, permanent neurological deficits caused by CNS injury and scarring that had occurred prior to the treatment can occur. Vasculitis in the posterior circulation was associated with worse prognosis. According to the current EFNS guidelines, adult patients with early LNB with CNS manifestations (including vasculitis) should be treated with intravenous (IV) ceftriaxone (2 g daily) for 14 days. The patients with late LNB with CNS manifestations (also including vasculitis) should be treated with IV ceftriaxone (2 g daily) for 3 weeks ([@B11]). Nonetheless, it should be noted that a recent study has indicated that oral doxycycline is as effective treatment for LNB as IV ceftriaxone ([@B81]). In the vast majority of patients, a significant improvement was obtained after antibiotics administration, indicating a direct vascular injury by *B. burgdorferi*. Many authors additionally used steroids. However, in some reported cases, clinical improvement was achieved only after additional immunosuppressive therapy with cyclophosphamide suggesting the additional role of immune mechanisms in the development of vasculitis.

Among fatal cases, one patient died in the acute stage due to extensive BA thrombosis ([@B57]). The other patient presented with an infarction in the territory of the left ACA and extensive changes in the BA and both MCAs, which subsequently evolved into cerebral edema leading to fatal transtentorial and subfalcine herniation ([@B51]). Another patient was admitted to hospital because of acute right-sided hemiparesis progressing to tetraparesis and respiratory failure in few hours. Cranial CT showed diffuse cerebral edema and MRI of the brain revealed multiple hyperintense lesions. The patient died a few days after being admitted to hospital due to cardiac arrest ([@B60]). The last patient who died developed severe hemiparesis and respiratory failure. The cause of death was bilateral pneumonia. In this patient, an autopsy was performed, which revealed infarcts in tegmentum and medulla oblongata. There was no evidence of atherosclerosis in the vascular lumen; however, the clear evidence of CNS vasculitis was observed ([@B26]).

There are some limitations to our study that are inherent to any systematic review. Limits in our results are due to incomplete information in the case descriptions on all variables, especially data on the history of preceding symptoms of Lyme disease or information about time from onset of symptoms suggestive of Lyme disease to onset of symptoms of cerebrovascular complications of LNB. Furthermore, data on additional steroids and antiplatelet drugs were only known for 55 and 38 patients, respectively. In three patients, there was a lack of outcome data. Although we have created a literature search algorithm to identify all cases of CNS vasculitis due to LNB, we cannot exclude an involuntary omission. However, despite these limitations, our review summarizes the epidemiology, clinical manifestations, neuroimaging, and outcomes in patients presenting with cerebrovascular manifestations of LNB.

Conclusion {#S5}
==========

It is concluded that patients with LNB-associated vasculitis usually achieve a favorable recovery. As a rare cause of stroke or TIA, cerebral vasculitis due to LNB should be considered. Several weeks/months before stroke onset, prodromal symptoms suggesting LNB, such as meningitis, cranial neuritis or radiculoneuritis, should prompt extensive diagnostics including CSF examination. Due to the fact that it can appear even in the absence of earlier more characteristic symptoms of Lyme disease, LNB-associated vasculitis should be excluded in all patients with vasculitis and multiple ischemic lesions of unknown origin, especially in those living in endemic areas. The lack of awareness of this manifestation of LNB might result in the delay of diagnosis, which might lead even to the patient's death. Perhaps, this presentation of LNB may occur more frequently than it is thought. In patients suspected of having *B. burgdorferi*-induced CNS vasculitis and stroke, the most useful and crucial imaging examination to evaluate cerebral vessels is cerebral angiography (conventional angiography, MRA, or CTA), which may reveal focal narrowing and dilatation or even total occlusion of the arteries.

Author Contributions {#S6}
====================

The conceiving and the conception of research were contributed by AG. The search strategies were designed by AG, JZ, AZ, and AK. The data were analyzed and interpreted and the final version of the manuscript was read and approved by AG, JZ, AZ, AK, OZ, BK, DJ, MH, and UŁ. The paper was written by AG, JZ, AZ, and UŁ.

Conflict of Interest Statement {#S7}
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer, NM, and handling editor declared their shared affiliation, and the handling editor states that the process nevertheless met the standards of a fair and objective review.

Funding {#S8}
=======

This study was funded by the Medical University of Białystok, Poland (grant number: N/ST/ZB/16/004/1127).

Supplementary Material {#S9}
======================

The Supplementary Material for this article can be found online at <http://journal.frontiersin.org/article/10.3389/fneur.2017.00146/full#supplementary-material>.

###### 

Click here for additional data file.

[^1]: Edited by: Guillaume Turc, Centre hospitalier Sainte-Anne, France

[^2]: Reviewed by: Nicolas Mélé, Centre hospitalier Sainte-Anne, France; Linxin Li, University of Oxford, UK

[^3]: Specialty section: This article was submitted to Stroke, a section of the journal Frontiers in Neurology
